5-Hydroxytryptamine2A (5-HT2A) receptor regulation in rat prefrontal cortex: Interaction of a phenethylamine hallucinogen and the metabotropic glutamate2/3 receptor agonist LY354740

Neuroscience Letters

Volumn 403, Issue 3, 2006, Pages 256-260

  Marek, Gerard J ^a,b   Wright, Rebecca A ^b   Schoepp, Darryle D ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

DOI; Glutamate; Hallucinogens; mGluR; Prefrontal cortex; Serotonin

Indexed keywords

AMINO ACID; EGLUMETAD; GLUTAMIC ACID; IODINE 123; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR AGONIST; PHENETHYLAMINE; PSYCHEDELIC AGENT; SEROTONIN; SEROTONIN 2A RECEPTOR; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 4-IODO-2,5-DIMETHOXYPHENYLISOPROPYLAMINE; AMPHETAMINE DERIVATIVE; BICYCLO COMPOUND; METABOTROPIC RECEPTOR; SEROTONIN 5 RECEPTOR; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BRAIN REGION; CONTROLLED STUDY; DENSITY; DOWN REGULATION; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS; ANIMAL; DRUG EFFECT; DRUG INTERACTION; DRUG POTENTIATION; METABOLISM; RADIOASSAY; SPRAGUE DAWLEY RAT;

AMPHETAMINES; ANIMALS; BICYCLO COMPOUNDS; DRUG INTERACTIONS; HALLUCINOGENS; MALE; PREFRONTAL CORTEX; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, SEROTONIN;

EID: 33745761335     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.05.021     Document Type: Article

References (35)

1. Aghajanian G.K., and Marek G.J. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36 (1997) 589-599
2. 2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release. Brain Res. 825 (1999) 161-171
3. 2A receptors in the rabbit. J. Pharmacol. Exp. Ther. 299 (2001) 1066-1072
4. Anji A., Kumari M., Hanley N.R.S., Bryan G.L., and Hensler J.G. Regulation of 5-HT2A receptor mRNA levels and binding sites in rat frontal cortex by the agonist DOI and the antagonist mianserin. Neuropharmacology 39 (2000) 1996-2005
5. 1C receptors. J. Pharmacol. Exp. Ther. 255 (1990) 843-857
6. 2A receptor occurs via the endosome pathyway in vitro. Mol. Pharmacol. 50 (1996) 306-313
7. Blackshear M.A., and Sanders-Bush E. Serotonin receptor sensitivity after acute and chronic treatment with mianserin. J. Pharmacol. Exp. Ther. 221 (1982) 303-308
8. 2 receptors and serotonergic axons in rat neocortex. Brain Res. 453 (1988) 315-328
9. 2 receptor binding in rat brain. Eur. J. Pharmacol. 109 (1985) 421-425
10. 2 receptors. Life Sci. 42 (1988) 2439-2445
11. Conn P.J., and Sanders-Bush E. Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT2 binding site. J. Neurosci. 6 (1986) 3669-3675
12. Frazer A., Offord S.J., and Lucki I. Regulation of serotonin receptors. In: Sanders-Bush E. (Ed). The Serotonin Receptors (1988), Humana, Clifton, NJ 319-365
13. Gewirtz J.C., Chen A.C., Terwilliger R., Duman R.C., and Marek G.J. Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors. Pharmacol. Biochem. Behav. 73 (2002) 317-326
14. 2A receptor density and associative learning. Psychopharmacology 172 (2004) 435-442
15. 2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogens in pyramidal cell apical dendrites. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 735-740
16. Kellar K.J., Cascio C.S., Butler J.A., and Kurtzke R.N. Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain. Eur. J. Pharmacol. 69 (1981) 515-518
17. Lopez-Gimenez J.F., Mengod G., Palacios J.M., and Vilaro M.T. Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907. Naunyn-Schmiedeberg's Arch. Pharmacol. 356 (1997) 446-454
18. Marek G.J., Wright R.A., Gewirtz J.C., and Schoepp D.D. A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex. Neuroscience 105 (2001) 379-392
19. 2A and group II metabotropic glutamate receptors in prefrontal cortex. J. Pharmacol. Exp. Ther. 292 (2000) 76-87
20. 3H]spiperone binding following focal frontal cortex lesions in the rat. Brain Res. 516 (1990) 127-131
21. Mayberg H.S., Robinson R.G., Wong D.W., Parikh R., Bolduc P., Starkstein S.E., Price T., Dannals R.F., Links J.M., Wilson A.A., Ravert H.T., and Wagner H.N. PET imaging of cortical S2 serotonin receptors after stroke: lateralized changes and relationship to depression. Am. J. Psychiatry 145 (1988) 937-943
22. 2 receptors in rat brain. Neuropsychopharmacology 2 (1989) 81-87
23. Miner L.A.H., Backstrom J.R., Sanders-Bush E., and Sesack S.R. Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience 116 (2003) 107-117
24. Monn J.A., Valli M.J., Massey S.M., Wright R.A., Salhoff C.R., Johnson B.G., Howe T., Alt C.A., Rhodes G.A., Robey R.L., Tizzano J.P., Kallman M.J., Helton D.R., and Schoepp D.D. Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. J. Med. Chem. 40 (1997) 528-537
25. Muschamp J.W., Regina M.J., Hull E.M., Winter J.C., and Rabin R.A. Lysergic acid diethylamide and (-)-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex. Brain Res. 1023 (2004) 134-140
26. 2 receptor antagonist. Eur. J. Pharmacol. 246 (1993) 73-80
27. 2 receptors in mouse brain. Mol. Pharmacol. 43 (1993) 84-89
28. Sanders-Bush E. Adaptive regulation of central serotonin receptors linked to phosphoinositide hydrolysis. Neuropsychopharmacology 3 (1990) 411-416
29. Schoepp D.D., Johnson B.M., Wright R.A., Salhoff C.R., Mayne N.G., Wu S., Cockerham S.L., Burnett J.P., Belagaje R., Bleakman D., and Monn J.A. LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors. Neuropharmacology 36 (1997) 1-11
30. 2A heteroceptors on thalamocortical glutamatergic neurons. J. Neurosci. 20 (2000) 8846-8852
31. Scruggs J.L., Schmidt D., and Deutch A.Y. The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats. Neurosci. Lett. 346 (2003) 137-140
32. Stockmeier C.A., and Kellar K.J. In vivo regulation of the serotonin-2 receptor in rat brain. Life Sci. 38 (1986) 117-127
33. Willins D.L., Berry S.A., Alsayegh L., Backstrom J.R., Sanders-Bush E., Friedman L., and Roth B.L. Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo. Neuroscience 91 (1999) 599-606
34. Zhang C., and Marek G.J. AMPA receptors mediate serotonin-2A receptor-induced EPSCs in layer V pyramidal cells of prefrontal cortex. Soc. Neurosci. Abstr. 26 (2000) 1427
35. Zhou F.-M., and Hablitz J.J. Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex. J. Neurophysiol. 82 (1999) 2989-2999